Literature DB >> 32221774

Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction.

Giovanni Cioffi1,2, Ombretta Viapiana3, Luigi Tarantini4, Federica Ognibeni3, Giovanni Orsolini3, Angelo Fassio3, Davide Gatti3, Maurizio Rossini3, Alessandro Giollo3.   

Abstract

Inflammatory arthritis, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS), are associated with both cancer and cardiovascular (CV) adverse events. Cancer and CV abnormalities have coincident etiologic and pathophysiologic pathways in RA/PsA/AS patients. However, a comprehensive evaluation of CV system has never been performed in these patients in relation to the presence of cancer. This study was designed to assess the possible relationships between CV abnormalities and cancer among RA/PsA/AS patients. Between March 2014 and March 2015, 414 patients (214 RA, 125 PsA, and 75 SA) in sinus rhythm without known cardiac disease underwent clinical and color Doppler echocardiographic evaluation and were prospectively followed up. Patients had a mean age of 58 ± 12 years, 64% women. Forty-two patients (10.1%) had a diagnosis of cancer (made before enrollment in 24 cases and in 18 cases during the 36 months of follow-up). Skin cancer was the most frequent malignancy found, followed by thyroid, colon, pancreas, and breast cancer. Patients who had cancer were older with higher systolic blood pressure, more frequent hypertension and moderate/high disease activity, left ventricular (LV) hypertrophy, diastolic dysfunction, and higher ascending aortic stiffness index (AOSI) than those who had not. At multivariate logistic regression analysis, LV diastolic dysfunction and abnormally high AOSI emerged as conditions associated with cancer together with older age and hypertension. Cancer in RA/PsA/AS adults without history of CV disease is closely associated with specific asymptomatic CV abnormalities, such as LV diastolic dysfunction and reduced vascular elasticity, which are independent of age and hypertension.

Entities:  

Keywords:  Ankylosing spondylitis; Aortic stiffness; Cancer; Left ventricular function; Psoriatic arthritis; Rheumatoid arthritis

Mesh:

Year:  2020        PMID: 32221774     DOI: 10.1007/s11739-020-02310-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  40 in total

1.  EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees.

Authors:  M Dougados; N Betteridge; G R Burmester; L Euller-Ziegler; F Guillemin; J Hirvonen; J Lloyd; S Ozen; J A P Da Silva; P Emery; J R Kalden; T Kvien; M Matucci-Cerinic; J Smolen
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 3.  The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Erica D Dommasch; Katrina Abuabara; Daniel B Shin; Josephine Nguyen; Andrea B Troxel; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2011-02-18       Impact factor: 11.527

Review 4.  Cancer-related inflammation: common themes and therapeutic opportunities.

Authors:  Frances R Balkwill; Alberto Mantovani
Journal:  Semin Cancer Biol       Date:  2011-12-24       Impact factor: 15.707

Review 5.  Malignancy as a comorbidity in rheumatic diseases.

Authors:  Carl Turesson; Eric L Matteson
Journal:  Rheumatology (Oxford)       Date:  2012-07-23       Impact factor: 7.580

Review 6.  Tumour necrosis factor and cancer.

Authors:  Frances Balkwill
Journal:  Nat Rev Cancer       Date:  2009-04-03       Impact factor: 60.716

7.  A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort.

Authors:  Rachael L Gross; Julie S Schwartzman-Morris; Michael Krathen; George Reed; Hong Chang; Katherine C Saunders; Mark C Fisher; Jeffrey D Greenberg; Chaim Putterman; Philip J Mease; Alice B Gottlieb; Joel M Kremer; Anna Broder
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

8.  Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: a population based cohort study.

Authors:  N Feltelius; A Ekbom; P Blomqvist
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Prevalence of malignancy in psoriatic arthritis.

Authors:  Sherry Rohekar; Brian D M Tom; Agnes Hassa; Cathy T Schentag; Vernon T Farewell; Dafna D Gladman
Journal:  Arthritis Rheum       Date:  2008-01
View more
  1 in total

1.  Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome.

Authors:  Giovanni Cioffi; Ombretta Viapiana; Luigi Tarantini; Giovanni Orsolini; Luca Idolazzi; Federica Ognibeni Sonographer; Andrea Dalbeni; Davide Gatti; Angelo Fassio; Maurizio Rossini; Alessandro Giollo
Journal:  Intern Emerg Med       Date:  2020-10-20       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.